OPHTHALMOLOGY

A Shift in Focus: A Refractive Presentation of Systemic Lupus Erythematosus
Joseph A, Wotipka E and Abel AS
Ocular Surface Squamous Neoplasia Masquerading as Viral Keratitis
Albarki H, Wong YL and Chan E
Dry Eye Disease: Search for a Better End Point
Shen J
A Small Volume Topical Ophthalmic Spray for Pupillary Dilation in Children: A Randomized, Masked Non-inferiority Trial
Godfrey A, Menon S, Takla P, Lu J, Chen T, Bass O, Brown M, Indaram M and Oatts JT
To evaluate the non-inferiority of mydriatic eye drops administered through a commercially available spray (Optejet, Hyperion DeFi, Inc.) compared to standard eye drops on pupillary dilation in children.
Dead Bag-Associated Uveitis-Glaucoma-Hyphema Syndrome
Cuesta PP, Safran S and Milman T
Which of These Fundus Images Was Created by Artificial Intelligence?
Cruz-Abrams OF and Abramson DH
Special Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2026 Revision)
Marmor MF, Ahn SJ, Ehlers JP, Melles RB, Mieler WF, Sarraf D, Yusuf IH and
The American Academy of Ophthalmology Recommendations on Screening for Hydroxychloroquine (HCQ) Retinopathy are now a decade old. This revision provides an update, based on current knowledge. Major points and changes are: NATURE OF TOXICITY: The retina typically remains clinically normal for many years on HCQ, but there is an unpredictable point at which signs of toxicity may develop.
Re: Oatts et al.: Ophthalmic Technology Assessment: Instrument-based screening for the detection of amblyopia and amblyopia risk factors: a report by the American Academy of Ophthalmology (Ophthalmology. 2025;132:1294-1303.)
Guimaraes S
Efficacy and safety of Syk/VEGFR-2 Dual-target Kinase Inhibitor (OT202) in Dry Eye: A Randomized, Vehicle-controlled, Phase 2 Trial
Wang H, Jin X, Zheng H, Zhao S, Chen L, Zhang M, Liu H, Xiong W, Li L, Wen F and Chen W
To evaluate the efficacy and safety of OT202, a first-in-class, dual-target kinase inhibitor of spleen tyrosine kinase (Syk) and vascular endothelial growth factor receptor 2 (VEGFR-2), for treating moderate-to-severe dry eye disease (DED).
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial
Do DV, Wykoff CC, Sivaprasad S, Brown DM, Boyer DS, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Cheng Y, Bhore R, Bai Z, Schmidt-Ott U, Schmelter T, Schulze A, Hasanbasic Z, Morgan-Warren PJ, Zhang X, Hirshberg B, Yancopoulos GD and
To follow up the previously published comparison of aflibercept 8 mg at extended dosing intervals versus aflibercept 2 mg every 8 weeks (2q8) in patients with diabetic macular edema (DME) through 48 weeks, we now report efficacy, durability, and safety analyses through 96 weeks.
Incidence and associated factors of myopic maculopathy progression after posterior scleral contraction in high myopia
Zhao J, Zhao X, Jiang Y, Gong Q, Xu X, Zhu S and Hu L
To explore the progression predictors of myopic maculopathy in highly myopic patients following posterior scleral contraction (PSC).
Giant Hidrocystoma of Brow and Zygomatic-Frontal Suture
Mueller AJ, DeGregorio R and Margo CE
Major Complications Following Strabismus Surgery: nine-year data from the IRIS® (Intelligent Research in Sight) Registry
Siatkowski RM, Morse CL, Gold RS, Li C, Peng X and Lum F
We aimed to identify occurrence rates and associated risk factors of major complications following strabismus surgery in a very large cohort.
LONG-TERM PROGRESSION OF ELLIPSOID ZONE LOSS AND ASSOCIATED FEATURES ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2
Raming K, Goerdt L, Begemann E, BsC NS, Rodriguez Garcia JL, Egan C, Lange C, Tzaridis S, Friedlander M, Heeren T, Issa PC, Holz FG, Pfau M and Pfau K
To characterize the detailed natural history of ellipsoid zone (EZ) loss progression in Macular Telangiectasia Type 2 (MacTel) and to identify structural predictors of disease acceleration using demographic and OCT-based parameters.
Ocular Transient Ischemic Episode in Carotid Artery Stenosis
Cao L, Wang H and Wu B
Hutchinson's Sign in Herpes Zoster Ophthalmicus: A Systematic Review and Meta-Analysis
Mihalache A, Yu P, Tao BK, Xie JS, Margolin EA and Micieli JA
Although traditionally associated with herpes zoster ophthalmicus (HZO), the predictive significance of Hutchinson's sign (HS, or nasociliary nerve involvement) for ocular complications has recently been debated. We conducted a systematic review and meta-analysis to evaluate the association between HS and ocular involvement in HZO.
Incidence, Etiology and Treatment of Corneal Perforations in Older Adults in the U.S
Aamir FB, Ali M, Dun C, Prescott CR, Soiberman U, Makary MA, Woreta FA and Srikumaran D
In this retrospective cohort study of 5,690 adults ≥ 65 years with non-traumatic corneal perforations, Black and older patients were less likely to receive keratoplasty, while older and lower-income patients more often underwent enucleation/evisceration.
Long-Term Persistent Angle Closure and Anatomical Changes After Laser Iridotomy in Primary Angle Closure Suspects
Servillo A, Tun TA, Yoo C, Kumar RS, Baskaran M, Nongpiur ME, Friedman DS, Foster PJ, Xu B and Aung T
To evaluate the proportion of subjects with, and anatomical predictors of, persistent angle-closure five years after laser peripheral iridotomy (LPI) in primary angle-closure suspects (PACS), and to assess anterior segment anatomical changes over the 5-year follow-up.
Iridescent Particle in Phacolytic Glaucoma
Fang Z and Zhang X
Intravascular Papillary Endothelial Hyperplasia (Masson's Tumor) of the Eyelid
Kates MM, Young KE and Esmaili N
Reply
Oatts JT, Chang MY and Pineles SL